RESOLVE-AF: Clinical Evaluation of the Ablacath™ Mapping Catheter and Ablamap® System Utilizing Electrographic Flow (EGF) Mapping to Resolve Extra-PV Sources of Atrial Fibrillation and Guide Ablation Therapy.

Sponsor:

Cortex

Code:

NCT05883631

Conditions

Atrial Fibrillation

Atrial Fibrillation, Persistent

Atrial Fibrillation Paroxysmal

Arrhythmia

Arrhythmias, Cardiac

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Electrographic Flow (EGF) mapping and ablation of EGF-identified sources of Atrial Fibrillation

Electrographic Flow (EGF) mapping (no ablation)

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information